financetom
Business
financetom
/
Business
/
Update: Methanex Q4 Adjusted Profit More Than Doubles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Methanex Q4 Adjusted Profit More Than Doubles
Jan 30, 2025 8:33 AM

11:08 AM EST, 01/30/2025 (MT Newswires) -- (Adds analyst comment and updates shares.)

Methanex ( MEOH ) late on Wednesday said its fourth-quarter adjusted profit, excluding most one-time items, more than doubled to US$84 million, or US$1.24 per share, from US$35 million, or US$0.52 per share.

Revenue in the three months ended Dec. 31 rose to US$949 million from US$922 million in the year-prior quarter. Adjusted EBITDA came in at US$224 million, rising from US$148 million.

The company produced 1.87-million tonnes of methanol during the quarter, up from 1.78-million tonnes. Total sales volume also rose to 2.56-million tonnes from 2.86-million tonnes.

"2024 was a significant year for Methanex ( MEOH ). Thanks to the dedication of our global team, we achieved the best safety performance in the company's history, successfully achieved commercial production at G3, and announced the acquisition of OCI Global's methanol business," Methanex ( MEOH ) chief executive Rich Sumner said.

RBC Capital Markets maintained its sector-perform rating and US$55.00 price target on the company's shares following the results.

RBC said Methanex's ( MEOH ) results were in line with estimates will have a neutral impact on the company's shares.

Methanex ( MEOH ) shares were last seen up $3.76 to $75.65 on the Toronto Stock Exchange.

Price: 75.99, Change: +4.10, Percent Change: +5.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Esperion Therapeutics Prices $75 Million Share Offering
Esperion Therapeutics Prices $75 Million Share Offering
Oct 8, 2025
03:25 AM EDT, 10/08/2025 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said late Tuesday it priced an underwritten public offering of 30 million shares at $2.50 apiece for expected gross proceeds of about $75 million. The company granted underwriters a 30-day option to purchase up to an additional 4.5 million shares. The offering is expected to close on or...
Teck Resources cuts copper production guidance at flagship Chilean mine QB
Teck Resources cuts copper production guidance at flagship Chilean mine QB
Oct 8, 2025
Oct 8 (Reuters) - Canadian miner Teck Resources Limited ( TECK ) on Wednesday cut its copper production forecast at its flagship Quebrada Blanca (QB) mine in Chile through 2028, following a company-wide operations review and its merger with Anglo American. Its 2026 copper output guidance was now 200,000-235,000 metric tons, from 280,000 to 310,000 tons previously. Teck also nearly...
North American Construction Prices Additional $125 Million Debt Offering
North American Construction Prices Additional $125 Million Debt Offering
Oct 8, 2025
03:34 AM EDT, 10/08/2025 (MT Newswires) -- North American Construction ( NOA ) said Tuesday it has priced $125 million worth of its 7.75% senior unsecured notes due 2030 at 103% of face value in a private placement. The offering is in addition to a $225 million worth of debt issued under identical terms in May, the company said. The...
Stellantis names new heads for Europe, manufacturing in latest executive shake-up
Stellantis names new heads for Europe, manufacturing in latest executive shake-up
Oct 8, 2025
MILAN (Reuters) -Stellantis ( STLA ) CEO Antonio Filosa has reshuffled the automaker's top ranks, naming new heads for its European operations and global manufacturing, just days after appointing a new CFO. Emanuele Cappellano, the head of the automaker's South American operations, will take over as head of 'Enlarged Europe and European Brands', replacing Jean-Philippe Imparato, who will now focus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved